| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |